The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women

This study examines the role of 11-oxygenated androgens and endocrine disruptors in androgen excess disorders, specifically polycystic ovary syndrome (PCOS) and idiopathic hirsutism (IH), in women. Involving 51 participants, the research found that women with PCOS had higher levels of 11-oxygenated androgens compared to those with IH and controls, while IH patients had lower levels than controls. Elevated bisphenol A (BPA) levels in obese women with PCOS suggest a potential exacerbation of metabolic issues, though BPA did not influence IH. The study highlights significant correlations between certain androgens and metabolic parameters, suggesting that 11-oxygenated androgens could be significant in diagnosing hyperandrogenic disorders, and that BPA might contribute to metabolic abnormalities in PCOS.